Repeat sequence motifs as well as unique sequences between nucleotides -150 and -22 of the human cytomegalovirus immediate-early 1 gene interact in vitro with nuclear proteins. We show that a transcriptional element between nucleotides -91 and -65 stimulated promoter activity in vivo and in vitro by binding specific cellular transcription factors. Finally, a common sequence motif, (T)TGG/AC, present in 15 of the determined binding sites suggests a particular class of nuclear factors associated with the immediate-early 1 gene.
The regulatory region of the human cytomegalovirus (HCMV) immediate-early 1 (IE1) gene contains several different functional domains. These include polymerase II promoter, enhancer, and repressor activities. The function of these regulatory domains has been shown in in vitro and in vivo expression systems (2, 9, 11, 12) . A remarkable feature of the IE1 regulatory region is its complex repetitive sequence composition. Our previous experiments have shown that the enhancer domain, between nucleotides -524 and -185, interacts with specific transcription factors which recognize several of the repeated sequence motifs as well as a unique sequence (4) . However, it was not clear and cannot be assumed from this study that repeat sequences, and in particular sequences outside the repeats, downstream of -185 bind specific transcription factors. Therefore, we have investigated the ability of DNA-binding proteins in transcriptionally active HeLa cell nuclear extract to interact with specific target sequences in the IEl promoter-regulatory region.
Nuclear and S100 extracts from HeLa cells were prepared (3) , and the nuclear extract was chromatographically fractionated as shown in Fig. 1A . We determined specific DNA-protein interactions by performing a mobility shift assay as described (8) . The fragment (E3) between nucleotides -185 and -14 incubated with crude nuclear extract resulted in several distinct nucleoprotein complexes, suggesting the binding of multiple factors (Fig. 1B, lane 2) . The cytoplasmic (S100) fraction did not contain significant binding activity (Fig. 1B, lane 3) , confirming that the binding proteins were of nuclear origin. The various protein fractions obtained after fractionation of the crude nuclear extract also resulted in a complex band shift pattern (Fig. 1B) . To delineate precisely at the nucleotide level sites of protein-DNA interaction, DNase I protection analyses were performed (Fig. 2) as described (4, 10) . In two respects, these data are in agreement with the mobility shift experimental results. First, protected regions were observed in only those column fractions which developed specific band shift patterns. Second, multiple regions of protection were (4) 7, 6 pu1 of crude nuclear extract from lactating rat mammary glands (MG). Nuclear extract from the rat mammary gland was prepared as described (6) . Arrows mark the positions of protein-induced DNase I-hypersensitive sites. Brackets indicate protected regions. Numbers refer to the nucleotide position with respect to the start site of transcription.
A plausible explanation for these apparently conflicting observations is that such trans-acting factors are a minor component of the HeLa cell nuclear extract and their detection is made possible by the extreme sensitivity of the transcription assay. In this connection, we asked whether these sequences had the ability to interact with nuclear proteins prepared from different sources. We found that mammary gland nuclear extract, similar to the HeLa cell extract, protected sequences between nucleotides -146 and -50. The exact boundaries of the protected regions were not the same as in HeLa extract, and additional hypersensitive sites were observed (Fig. 2, lanes 7) . Moreover, HCMV IE1 promoter sequences between -50 and -22 were clearly protected with mammary gland extract. This observation supports the suggestion that these sequences can interact with specific nuclear factors.
Since 3) and pCMV(-65)CAT (lanes 4 to 6) after preincubating the nuclear extract with competitor DNA. The conditions of the in vitro transcription competition reactions were the same as described previously (4) . A 15-fold excess of the following competitors was used: pUC19 cut with HaeIII ( lanes 1 and 4) , fragment El covering IEi enhancer sequence between nucleotides -524 and -311 (lanes 2 and 5), and fragment E3 covering IEl enhancer-promoter sequences between nucleotides -185 and -14 (lanes 3 and 6) . The DNA fragments El and E3 were gel purified from their respective plasmids, pEi and pE3 (4), after cleaving with the restriction endonucleases EcoRI and Hindlll. The arrow marks the IEi promoter-specific transcript. scription (Fig. 3A) . In agreement with this, runoff in vitro transcription analysis of these plasmids resulted in approximately 5-to 10-fold more specific transcript molecules from pCMV(-91)CAT than from the pCMV(-65)CAT template (Fig. 3B) . Thus, in two indepedent assay systems, a promoter-proximal transcription regulatory sequence between -91 and -65 of the IEl gene was functional in vivo and in vitro.
To determine whether the transcriptional stimulation mediated by these sequences involved the binding of transacting factors, we used an in vitro transcription competition assay (4) . The same extract and DNA template preparations were assayed in the presence of nonspecific DNA and fragment E3 (-185 to -14) as specific competitor. The activity of the IEl promoter in pCMV(-91)CAT and pCMV(-65)CAT was reduced below the basal level of transcription in the presence of specific competitor (Fig. 3C,   lanes 1, 3, 4, and 6 ). This observation suggests that the transcriptional activities of both pCMV(-91)CAT and pCMV(-65)CAT involve the interaction of specific transacting factors. To examine whether the stimulatory activity of sequences present in pCMV(-91)CAT was associated with enhancer elements, competition assays were performed with an IEl enhancer-specific fragment. Transcriptional stimulation of the IEl promoter in pCMV(-91)CAT but not in pCMV(-65)CAT was selectively reduced by the enhancer sequences between -524 and -311 (Fig. 3C, lanes 2 and 5) . The reduction of transcriptional activity of pCMV(-91)CAT to about the level observed with pCMV(-65)CAT suggests that a common or closely related trans-acting factor(s) interacted with the IEl enhancer and upstream promoter sequences. Furthermore, this suggests that the enhancer domain extends to nucleotides between -91 and -65.
Three lines of evidence support the conclusion that the -70 to -50 region is important for stimulating transcription from the IEl promoter. The El fragment contains two 19-bp palindromic repeats which showed homology with the sequence between -70 and -50 and competed effectively for transcriptional stimulation in the in vitro competition experiments; the transcriptionally active HeLa cell nuclear extract contained a factor(s) which specifically interacted with the -70 to -50 region; and the intact 5' half of the protected palindromic sequence was deleted in pCMV(-65)CAT, which showed reduced transcriptional activity in vivo and in vitro (Fig. 4) .
In summary, on the basis of this work and our previous experiments (4), we are able to conclude the following. Most, but not all, of the repetitive sequences which have been implicated in the activity of the enhancer (2, 11) are targets for specific transcription factors. The extent of protection for a repetitive sequence varies within members of a class of repeat elements (e.g., 19-bp repeats) as well as between different classes of repeat elements (e.g., 17-and 18-bp repeats). We show that sequences outside the repeat elements, between nucleotides -445 to -425 and -120 to -107, were also targets for specific nuclear proteins, further increasing the order of complexity of this region. The 5'-end half of 15 of the binding sites thus far determined (4, 6, 7; this work) have a common sequence motif, (T)TG(G/A)C, which may suggest a particular class of nuclear factors associated with the HCMV IBE gene.
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